JP2022513437A5 - - Google Patents

Info

Publication number
JP2022513437A5
JP2022513437A5 JP2021529785A JP2021529785A JP2022513437A5 JP 2022513437 A5 JP2022513437 A5 JP 2022513437A5 JP 2021529785 A JP2021529785 A JP 2021529785A JP 2021529785 A JP2021529785 A JP 2021529785A JP 2022513437 A5 JP2022513437 A5 JP 2022513437A5
Authority
JP
Japan
Prior art keywords
seq
antigen
binding fragment
monoclonal antibody
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021529785A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513437A (ja
JP7478149B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/063729 external-priority patent/WO2020113084A1/en
Publication of JP2022513437A publication Critical patent/JP2022513437A/ja
Publication of JP2022513437A5 publication Critical patent/JP2022513437A5/ja
Application granted granted Critical
Publication of JP7478149B2 publication Critical patent/JP7478149B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021529785A 2018-11-28 2019-11-27 治療用第xii因子抗体 Active JP7478149B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862772235P 2018-11-28 2018-11-28
US62/772,235 2018-11-28
PCT/US2019/063729 WO2020113084A1 (en) 2018-11-28 2019-11-27 Therapeutic factor xii antibody

Publications (3)

Publication Number Publication Date
JP2022513437A JP2022513437A (ja) 2022-02-08
JP2022513437A5 true JP2022513437A5 (cg-RX-API-DMAC7.html) 2022-09-29
JP7478149B2 JP7478149B2 (ja) 2024-05-02

Family

ID=69024611

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021529785A Active JP7478149B2 (ja) 2018-11-28 2019-11-27 治療用第xii因子抗体

Country Status (5)

Country Link
US (1) US12134657B2 (cg-RX-API-DMAC7.html)
EP (1) EP3886982A1 (cg-RX-API-DMAC7.html)
JP (1) JP7478149B2 (cg-RX-API-DMAC7.html)
CN (1) CN113423465B (cg-RX-API-DMAC7.html)
WO (1) WO2020113084A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL298989A (en) * 2020-07-03 2023-02-01 CSL Innovation Pty Ltd High concentration promotion of factor XII antigen binding proteins
CN116265945B (zh) * 2022-01-05 2025-12-09 上海迈晋生物医药科技有限公司 抗凝血药物的生物学活性检测方法
CN115819500B (zh) * 2022-07-25 2026-08-07 昆明医科大学第一附属医院 一种抗血小板聚集的穿膜多肽及其应用
EP4729546A1 (en) * 2023-06-16 2026-04-22 Jiangsu BioJeTay Biotechnology Co., Ltd. Antibody specifically recognizing factor xiia and use thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4957939A (en) 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4472509A (en) 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4938948A (en) 1985-10-07 1990-07-03 Cetus Corporation Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
JPH049249A (ja) 1990-04-27 1992-01-14 Kusuda:Kk 塗型剤吹き付け機
US20080219998A1 (en) 2001-12-07 2008-09-11 Andras Gruber Anti-Thrombotic Agents
CN101102819A (zh) 2004-12-23 2008-01-09 Csl百灵有限公司 血栓的形成和/或稳定化的预防
CN202179824U (zh) 2011-07-22 2012-04-04 北京美亚视景创恒科技有限公司 数字健身设备集群系统
HRP20250164T1 (hr) 2011-07-22 2025-04-11 Csl Behring Gmbh Inhibitorna monoklonska antitijela protiv faktora xii/xiia i njihove uporabe
WO2014089493A1 (en) 2012-12-07 2014-06-12 Vanderbilt University Antibodies against factor xii and uses thereof
DK3157548T3 (da) * 2014-06-18 2021-09-06 Csl Behring Gmbh Terapi anvendelse af en faktor xii-inhibitor i en neurotraumatisk sygdom

Similar Documents

Publication Publication Date Title
CN109963591B (zh) B7h3抗体-药物偶联物及其医药用途
ES2595091T3 (es) Composiciones farmacéuticas con resistencia a CEA soluble
JP2023002615A5 (cg-RX-API-DMAC7.html)
MX2010013236A (es) Inmunoglobulinas de dominio variable doble y usos de las mismas.
MX2010011955A (es) Inmunoglobulinas de dominio variable doble y usos de las mismas.
TW202126693A (zh) 標靶bcma的抗體、雙專一性抗體及其用途
JP2018531219A (ja) Pd−l1抗体
JP2018531219A6 (ja) Pd−l1抗体
JP2021510736A5 (cg-RX-API-DMAC7.html)
RU2009123409A (ru) Новые антипролиферативные антитела
JP2024504390A5 (cg-RX-API-DMAC7.html)
JP2020522488A5 (cg-RX-API-DMAC7.html)
JP2024514109A (ja) 抗cntn4抗体及びその使用
CN117279950B (zh) 一种靶向il-18bp的抗体及其应用
JP2018528759A5 (cg-RX-API-DMAC7.html)
JP2026027248A (ja) 抗原結合分子およびその使用
CN114591434A (zh) 抗Siglec15抗体及其制备方法和用途
JP2019510474A (ja) トロンビン抗体、その抗原結合フラグメント及び医薬用途
JP2024542944A5 (cg-RX-API-DMAC7.html)
US20250161441A1 (en) Medicine comprising combination of anti-mutant-calr antibody and another drug
CN120187752A (zh) 人源化的l1cam抗体药物偶联物
JP2024547122A5 (cg-RX-API-DMAC7.html)
JP2024505430A5 (cg-RX-API-DMAC7.html)
JP2023536630A5 (cg-RX-API-DMAC7.html)
JP2024533162A5 (cg-RX-API-DMAC7.html)